Here's Why You Should Add Maximus Stock to Your Portfolio Now

10.03.25 17:35 Uhr

Werte in diesem Artikel
Aktien

63,50 EUR -1,00 EUR -1,55%

13,60 EUR -0,40 EUR -2,86%

Maximus, Inc. MMS stands out as a strong investment opportunity, backed by solid fundamentals and a favorable Zacks rating. The company’s consistent financial performance, strategic acquisitions and strong government partnerships position it well for continued growth. With a history of stable dividend payments and a healthy liquidity position, Maximus demonstrates resilience and reliability in the market.Let’s take a closer look at what makes MMS an attractive choice for investors.MMS carries a Zacks Rank #2 (Buy) and a VGM Score of B. Our research shows that stocks with a VGM Score of A or B, when combined with a Zacks Rank #1 (Strong Buy) or 2, offer the best investment opportunities for investors. Thus, the company appears to be a compelling investment proposition.The Zacks Consensus Estimate for fiscal 2025 earnings is pegged at $6.08, up 2% in the past 60 days. Two estimates for fiscal 2025 earnings have been revised upward, with no downward revisions in this time frame.With more than 40 years of experience, Maximus has grown to be a leading operator of government health and human services programs globally. The company’s business process management expertise and its ability to deliver cost-effective, efficient and high-scale solutions position it as a lucrative partner to governments.Maximus maintains solid relationships and a strong reputation with governments. Its long-term contracts provide the company with predictable recurring revenue streams. It continuously seeks long-term relationships with clients in not only those markets where they operate but also in adjacent ones.Maximus, Inc. Revenue (TTM) Maximus, Inc. revenue-ttm | Maximus, Inc. QuoteMaximus has been active on the acquisition front,and this strategy has enabled itto expand its business processes, knowledge and client relationships, enhance technical capabilities and gain additional skill sets. Strategic acquisitions also complement the company’s long-term organic growth strategy. The 2022 acquisition of Stirling Institute of Australia, which provides vocational training to Australians seeking to improve their knowledge and qualifications, has strengthened its employment services. Another acquisition, BZ Bodies, has strengthened Maximus’ services within the U.K.The company has a solid track record of dividend payments. During fiscal 2021, 2022, 2023 and 2024, Maximus paid cash dividends of $68.8 million, $68.7 million, $68 million and $72.9 million, respectively. These steady payouts indicate the company’s commitment to create value for shareholders and underline its confidence in its business.Maximus' current ratio (a measure of liquidity) at the end of first-quarter fiscal 2025 was pegged at 1.72, higher than the industry’s 1.45. A current ratio of more than 1 indicates that the company should not have problems meeting its short-term obligations.Other Stocks to ConsiderSome other top-ranked stocks in the broader Zacks Business Services sector are AppLovin Corporation APP and Booz Allen Hamilton BAH.AppLovin Corporation currently sports a Zacks Rank of 1. You can see the complete list of today’s Zacks #1 Rank stocks here.APPhas a long-term earnings growth expectation of 20%. It delivered a trailing four-quarter earnings surprise of 23.5%, on average.Booz Allen Hamilton currently carries a Zacks Rank #2. BAH has a long-term earnings growth expectation of 14%. BAH has an impressive earnings surprise history, having outpaced the Zacks Consensus Estimate in three of the trailing four quarters and missed once. The average beat is 6.7%.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Booz Allen Hamilton Holding Corporation (BAH): Free Stock Analysis Report Maximus, Inc. (MMS): Free Stock Analysis Report AppLovin Corporation (APP): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Maximus

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Maximus

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Maximus Inc.

Wer­bung

Analysen zu Maximus Inc.

DatumRatingAnalyst
08.05.2018Maximus OverweightFirst Analysis Securities
08.02.2018Maximus HoldMaxim Group
04.05.2017Maximus HoldMaxim Group
07.04.2017Maximus HoldCanaccord Adams
04.12.2015Maximus BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
08.05.2018Maximus OverweightFirst Analysis Securities
04.12.2015Maximus BuyStifel, Nicolaus & Co., Inc.
12.11.2015Maximus BuyMaxim Group
06.08.2015Maximus BuyMaxim Group
07.05.2015Maximus BuyMaxim Group
DatumRatingAnalyst
08.02.2018Maximus HoldMaxim Group
04.05.2017Maximus HoldMaxim Group
07.04.2017Maximus HoldCanaccord Adams
24.08.2006Update Maximus Inc.: HoldMatrix Research
15.07.2005Update Maximus Inc.: NeutralSun Trust Robinson Humphrey
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Maximus Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen